Pharmaceutical Technology® spoke with Dr. Weite Oldenziel, CEO of Ofichem, before CPHI Frankfurt 2025 to get his perspective ...

Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...

Cambrex will invest $120M to expand U.S. drug manufacturing, boosting API capacity at its Iowa site and adding jobs amid ...

North America: Largest market, powered by high drug consumption, strong regulatory frameworks, and advanced biotech manufacturing infrastructure. Asia Pacific: Fastest-growing, led by India's contract ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qqllt2/breast) has announced the addition of the "Breast Cancer-Global API ...

"AstraZeneca sets $4.5bn Virginia API plant construction in motion" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

Emzor Pharmaceutical Industries Limited, a leading pharmaceutical company in Nigeria, has announced a ground-breaking $230 million investment in a new Active Pharmaceutical Ingredients (API) ...

Cisplatin, a crucial chemotherapy drug, has been in short supply since February. NBC News mapped the drug’s journey across the globe to show how the shortage came to be. By Berkeley Lovelace Jr. Aug.

India imposes minimum import price (MIP) on Sulphadiazine API, restricting imports below Rs.1,774 per kg until September 30, 2026.

President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports account for a ...

The US drug regulator has turned its lens on Hetero, issuing back-to-back Form 483s to its API Unit 9 and warehouse in ...